Ligand validation:8OL9

0GJ: L-alpha-glutamyl-N-{(1S)-4-{[amino(iminio)methyl]amino}-1-[(1S)-2-chloro-1-hydroxyethyl]butyl}glycinamide

0GJ is a Ligand Of Interest in 8OL9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8OL9_0GJ_H_303	13%	58%	0.238	0.788	0.66	0.96	-	2	2	0	96%	0.9615
5JBB_0GJ_S_302	84%	16%	0.093	0.954	2.1	1.58	4	8	0	0	100%	0.9615
5JB8_0GJ_S_302	65%	18%	0.119	0.919	2.18	1.41	4	5	0	0	100%	0.9615
7AHV_0GJ_H_501	36%	8%	0.217	0.91	3.19	1.41	6	4	0	0	100%	0.9615
4BXW_0GJ_B_1412	68%	49%	0.165	0.977	0.91	1.05	1	1	3	0	100%	0.9615
7AHU_0GJ_C_301	62%	6%	0.15	0.949	3.22	1.91	6	4	4	0	96%	0.9615
5WI6_0GJ_A_302	45%	18%	0.183	0.913	2.22	1.3	5	3	0	0	100%	0.9615

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.